Target intelligence / Profile preview

Ribosomal protein L21 pseudogene 44 (RPL21P44)

Target
RPL21P44
Molecular classification
Processed pseudogene, Other
01

Overview

Ribosomal protein L21 pseudogene 44 is a processed pseudogene found on chromosome 4q12. Pseudogenes are genomic DNA sequences similar to normal genes but nonfunctional; RPL21P44 does not encode a protein and is not expressed. It is derived from the ribosomal protein L21 parent locus, which is part of the large ribosomal 60S subunit. While some pseudogenes may have regulatory roles, there is no evidence in the literature that RPL21P44 has functional or disease relevance[1][5][7]. In summary, RPL21P44 is **not a therapeutic target**, but a noncoding pseudogene. Many ribosomal protein genes, including RPL21, have multiple pseudogenes[7], and their canonical names follow the format "ribosomal protein [subtype] pseudogene [number]." Ribosomal protein L21 (RPL21), the parent gene, is clinically relevant due to its role in ribosome function and has associations with diseases such as Hypotrichosis simplex of the scalp[3][6], but the pseudogene RPL21P44 does not share these functions.

Other names
RPL21_17_477
02

Biological functions

None. Pseudogenes like RPL21P44 generally lack biological function unless specifically repurposed for regulatory roles, for which no evidence is available for RPL21P44
03

Disease associations

None. No association reported for this specific pseudogene with any disease. The parent gene RPL21 has noted clinical relevance, but not the pseudogene.

Beyond the preview

Go deeper on Ribosomal protein L21 pseudogene 44 (RPL21P44).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L21 pseudogene 44 (RPL21P44).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call